نتایج جستجو برای: subconjunctival bleeding

تعداد نتایج: 59523  

Journal: :Scholars Journal of Medical Case Reports 2020

Journal: :Investigative ophthalmology & visual science 2004
Lisa A Ostrin Laura J Frishman Adrian Glasser

PURPOSE Pirenzepine is suggested to be a relatively selective muscarinic (M(1)) antagonist and is currently under investigation for the treatment of myopia. Atropine, a nonselective M-type antagonist, is used in the treatment of myopia, but has undesired ocular and systemic side effects. An M(1)-specific antagonist may decrease side effects and remain effective at reducing the progression of my...

Journal: :Indian Journal of Ophthalmology 2007

Journal: :Arquivos brasileiros de oftalmologia 2017
Gerson Jorge Aparecido Lopes Antonio Marcelo Barbante Casella Ana Paula Oguido Tiemi Matsuo

Purpose: To evaluate and compare the effects of topical application and subconjunctival injection of bevacizumab on corneal neovascularization (CNV) in rabbits' eyes after chemical burning of the cornea. Methods: The animals were randomly distributed into four groups of five animals. In one group, the drug was instilled, while in another, it was administered by subconjunctival injection. The ...

Journal: :Investigative ophthalmology & visual science 2007
Stephanie H Kim Craig J Galbán Robert J Lutz Robert L Dedrick Karl G Csaky Martin J Lizak Nam Sun Wang Ginger Tansey Michael R Robinson

PURPOSE Sustained-release intravitreal drug implants for posterior segment diseases are associated with significant complications. As an alternative, subconjunctival infusions of drug to the episclera of the back of the eye have been performed, but results in clinical trials for macular diseases showed mixed RESULTS To improve understanding of transscleral drug delivery to the posterior segme...

Journal: :Investigative ophthalmology & visual science 2009
Wei-Li Chen Chung-Tien Lin Nien-Ting Lin I-Hua Tu Jing-Wen Li Lu-Ping Chow Kwan-Rong Liu Fung-Rong Hu

PURPOSE Bevacizumab is a potent recombinant humanized monoclonal antibody directed against vascular endothelial growth factor (VEGF). The purpose of this study was to evaluate the therapeutic effect of subconjunctival injection of bevacizumab on corneal neovascularization (NV) in different rabbit models. METHODS Several rabbit models of corneal NV were used, including (1) a corneal micropocke...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید